newsmetry
rusign inget started
macro

JP Morgan raises Eli Lilly price target to $1650, keeps Overweight rating

JP Morgan kept its Overweight rating on Eli Lilly and lifted the price target to $1650 from $1500, according to TradingView citing Benzinga data.

published on Newsmetry
original source published

the same feed is available to bots and dashboards through the api. connect the api →

Newsmetry newsroom

what happened

JP Morgan analysts kept their Overweight rating on Eli Lilly shares and raised the price target by 10%, from $1500 to $1650. TradingView notes that this target implies roughly 16.4% upside from the October 30 close of $1417.54.

The same TradingView list shows other updates from October 30: Citigroup holds Buy with a $1650 target, Scotiabank Sector Outperform at $1605, Morgan Stanley Overweight at $1596, Wells Fargo Overweight at $1500, and Truist Securities reiterated Buy at $1612. Across the five most recent notes over the past 30 days, targets range from $1500 to $1650.

why it matters

Analyst updates like this usually shape sentiment around a stock but rarely become a major event for the broader market. Investors typically weigh them alongside the company's financial results and the wider pharmaceutical sector outlook.

tags

Analyst RatingStockUnited States

instruments

Eli Lilly

sources

  1. JP Morgan maintains Eli Lilly at Overweight, raises price target to $1650 from $1500 — TradingView, 30 October 2026 at 22:13 UTC
  2. JP Morgan maintains APi Group at Overweight, raises price target to $55 from $50 — TradingView, 30 October 2026 at 22:20 UTC
  3. JP Morgan maintains AGCO at Overweight, raises price target to $145 from $140 — TradingView, 30 October 2026 at 22:16 UTC
  4. JP Morgan maintains Bel Fuse at Overweight, raises price target to $360 from $330 — TradingView, 30 October 2026 at 22:25 UTC
  5. JP Morgan maintains Avery Dennison at Overweight, raises price target to $200 from $190 — TradingView, 30 October 2026 at 22:21 UTC
  6. JP Morgan maintains Citigroup at Overweight, raises price target to $148.50 from $147 — TradingView, 30 October 2026 at 22:31 UTC
  7. JP Morgan maintains Churchill Downs at Overweight, raises price target to $120 from $118 — TradingView, 30 October 2026 at 22:29 UTC
  8. JP Morgan maintains Forbright at Overweight, raises price target to $23 from $22 — TradingView, 30 October 2026 at 22:39 UTC

prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.

alerts on your topics, the morning digest and the api — in your account.

get stories in real time ↗

related stories